Medicare
- Report
The Economic Effects of Waiting to Stabilize Federal Debt
CBO analyzes the economic effects of waiting to stabilize federal debt. The longer action is delayed, the larger the policy changes needed to stabilize debt. The timing and type of policy would determine its effects on different age and income groups.
- Presentation
A Discussion of Recent Research on Health Care Prices: Prescription Drugs, Hospitals’ Services, and Physicians’ Services
Presentation by Michael Cohen, an analyst in CBO’s Health Analysis Division, and Tamara Hayford, Chief of CBO’s Health Policy Studies Unit, at the Congressional Research Service.
- Presentation
Variation in Prices for Hospitals’ Services
Presentation by Michael Cohen, an analyst in CBO’s Health Analysis Division, at the American Academy of Actuaries.
- Presentation
The Contribution of Changes in Drug Mix and Price Growth to the Rising Costs of Brand-Name Drugs in Medicare Part D
Presentation by Tamara Hayford, Chief of CBO’s Health Policy Studies Unit, at the Association for Public Policy Analysis & Management 2021 Annual Research Meeting.
- Report
Additional Information Concerning the Budgetary Effects of H.R. 3076, the Postal Service Reform Act of 2022
In a letter to Senator Scott, CBO addresses several questions concerning the agency's assessment of the budgetary effects of H.R. 3076, the Postal Service Reform Act of 2022, which was transmitted on February 4, 2022.
- Report
Prescription Drugs: Spending, Use, and Prices
CBO examines trends in nationwide spending on prescription drugs over the 1980–2018 period. CBO also provides a detailed analysis of trends in spending, use, and prices in the Medicare Part D and Medicaid programs over the 2009–2018 period.
- Presentation
Paying for Drugs in Medicare Part D Under Current Law and Under Proposals to Redesign the Program
In 2020, about three-fourths of Medicare beneficiaries were enrolled in Part D, the optional prescription drug benefit. They obtain coverage from private insurers, either through a stand-alone drug plan or through a Medicare Advantage plan.
- Report
The Budgetary Effects of Major Laws Enacted in Response to the 2020–2021 Coronavirus Pandemic, December 2020 and March 2021
CBO describes how two laws enacted in December 2020 and March 2021 in response to the 2020–2021 coronavirus pandemic will affect federal spending, revenues, and the deficit.
- Report
Additional Information About the Budget Outlook: 2021 to 2031
This document provides additional information about the baseline budget projections that CBO released on February 11, 2021.
- Report
The 2021 Long-Term Budget Outlook
CBO presents its projections of the federal budget for the next 30 years if current laws governing taxes and spending generally did not change. Growth in revenues would be outpaced by growth in spending, leading to rising deficits and debt.